Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Jeffersonia diphylla

ABSTRACT: Jeffersonia diphylla Transcriptome or Gene expression

PROVIDER: PRJNA178598 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR610306.fastq.gz	Fastqsanger.gz

Items per page:

1 - 1 of 1

Similar Datasets

Jeffersonia diphylla

Project description:Jeffersonia diphylla Transcriptome or Gene expression

| PRJNA178661 | ENA

Mitella diphylla

Project description:Mitella diphylla overview

| PRJNA551075 | ENA

Jeffersonia diphylla

Project description:Jeffersonia diphylla overview

| PRJNA179115 | ENA

Mitella diphylla

Project description:Mitella diphylla Genome sequencing and assembly

| PRJNA483165 | ENA

Extract of Chamaecrista diphylla Leaves

Project description:Constituents of Chamaecrista diphylla (L.) Greene Leaves with Potent Antioxidant Capacity: A Feature-Based Molecular Network Dereplication Approach

2022-06-17 | MSV000089677 | MassIVE

GNPS Extract of Chamaecrista diphylla Leaves

Project description:Constituents of Chamaecrista diphylla (L.) Greene Leaves with Potent Antioxidant Capacity: A Feature-Based Molecular Network Dereplication Approach

2022-06-17 | MSV000089677 | GNPS

Biomarks of Resistance to Cetuximab in Colorectal Cancer

Project description:Interventions: A group:Before using cetuximab;B group:After progression of disease:no Primary outcome(s): KRAS gene sequence;NRAS gene sequence;BRAF gene sequence;PIK3CA gene sequence;EGFR gene sequence;EGFR gene copy numbers;EGFR expression;Her2 expression;c-Met expression;PTEN expression Study Design: historical control

| 2671639 | ecrin-mdr-crc

The complete plastid genome of <i>Jeffersonia diphylla</i> and its phylogenetic position inference.

Project description:Jeffersonia diphylla, which belongs to Berberidaceae, is a perennial herb native to North America. In the present study, we determined the first plastome of J. diphylla using genome skimming approach. The pastome of J. diphylla is 152,842 bp in length, with a large single copy region (LSC) of 82,266 bp and a small single copy region (SSC) of 19,284 bp separated by a pair of inverted repeats (IRs) of 25,646 bp. It encodes 113 unique genes, consisting of 79 protein-coding genes, 30 tRNA genes, and four rRNA genes, with 19 duplicated genes in the IR regions. Phylogenetic analysis indicates that J. diphylla is sister to Plagiorhegma dubium, subsequently is sister to a clade including Diphylleia, Sinopodophyllum, Podophyllum, Dysosma, Achlys, and Epimedium.

| S-EPMC7720998 | biostudies-literature

Constituents of Chamaecrista diphylla (L.) Greene Leaves with Potent Antioxidant Capacity: A Feature-Based Molecular Network Dereplication Approach.

Project description:Chamaecrista diphylla (L.) Greene (Fabaceae/Caesalpiniaceae) is a herbaceous plant that is widely distributed throughout the Americas. Plants from this genus have been used in traditional medicine as a laxative, to heal wounds, and to treat ulcers, snake and scorpion bites. In the present study, we investigated the chemical composition of Chamaecrista diphylla leaves through a mass spectrometry molecular network approach. The oxygen radical absorbance capacity (ORAC) for the ethanolic extract, enriched fractions and isolated compounds was assessed. Overall, thirty-five compounds were annotated for the first time in C. diphylla. Thirty-two of them were reported for the first time in the genus. The isolated compounds 9, 12, 24 and 33 showed an excellent antioxidant capacity, superior to the extract and enriched fractions. Bond dissociation energy calculations were performed to explain and sustain the antioxidant capacity found. According to our results, the leaves of C. diphylla represent a promising source of potent antioxidant compounds.

| S-EPMC8150882 | biostudies-literature

TR study of ‘multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer&quot

Project description:Primary outcome(s): Cancer-related gene alteration, expression of protein, and expression of RNA

| 2645675 | ecrin-mdr-crc